ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide
C40H69N5O7
732 g/mol
APIDanger

L-Valinamide, N,N-dimethyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydro xy-1-methyl-

CAS160800-57-7EC814-537-0
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is an active pharmaceutical ingredient with a complex macrocyclic structure containing multiple amide groups, ether linkages, and an aromatic ring. It is used as a pharmaceutical raw material in the manufacturing of finished drug products.

pharmaceutical raw material for drug product manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 160800-57-7

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongStructure SimilarSimilarity 0.87

Monomethyl auristatin E

CAS474645-27-7

pharmaceutical intermediate

StrongStructure SimilarSimilarity 0.87

Vedotin

CAS646502-53-6

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.78

Auristatin F

CAS163768-50-1

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.77

Mc-MMAE

CAS863971-24-8

pharmaceutical raw material

ReferenceSame Category

Norfentanyl

CAS1609-66-1

pharmaceutical raw material

ReferenceSame Category

Deucravacitinib

CAS1609392-27-9

pharmaceutical raw material

ReferenceSame Category

SEL120-34A HCl

CAS1609452-30-3

pharmaceutical raw material

ReferenceSame Category

Silodosin

CAS160970-54-7

pharmaceutical raw material

Safety Reference

Health Hazard
Health Hazard
Danger
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name

(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide

InChIKey

WOWDZACBATWTAU-FEFUEGSOSA-N

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C

Synonyms (8)
  • Auristatin E
  • Auristatin E (GMP)